A new market research report by Transparency Market Research, titled “Periodontal Disease Therapeutics Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019”, presents a comprehensive analysis of the global periodontal disease therapeutics market in terms of both volume and revenue. Insights on the market’s competition have been presented by employing analysis tools such as Porter’s five forces model. The report also includes an analysis on the factors driving and restraining the growth of the market and entails a subsequent analysis of the prevalent trends in the market.
The technological breakthroughs taking place in the global periodontal disease therapeutics market have also been detailed upon in this market. A number of tables and graphs have also been employed for an accurate presentation of various segments present in the market. The drugs that have been introduced in the market and the drugs that are still in pipeline have also been reviewed under this study.
Periodontal (gums) diseases comprise infections of gums and their surrounding tissue which results in loosening of teeth. Periodontal diseases are of two forms including periodontitis and gingivitis. Amongst these, gingivitis refers to the inflammation of gums and comes before periodontitis. The global periodontal disease therapeutics market is fuelled by the increasing occurrence of diabetes which is amongst the key predisposing factors for numerous infections caused in the body including infections of the gums, etc. In addition, the increasing hormonal changes and huge count of individuals indulging in smoking also result in increased gum problems, thus driving the development of the overall periodontal disease therapeutics market. On the other hand, the soaring cost of branded drugs may inhibit the growth of this market in emerging nations.
Download exclusive Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2026
In the next section of the report, the segmentation of the market has been presented. In terms of therapeutic drugs, the report segments the periodontal disease therapeutics market into drug therapy which can further be segmented into Periostat, Atridox, Arestin, and PerioChip. In terms of geography, the periodontal disease therapeutics market is anticipated to expand in Asia Pacific and in numerous nations of the Middle East and Latin America due to the increasing awareness amongst people regarding oral hygiene and health. On the other hand, the regions of North America and Europe will also take a dominant share in the market due to the enhanced reimbursement scenario, growing awareness amongst individuals, and the increasing spending capacities of individuals residing in these regions.
The prominent players in the global periodontal disease therapeutics market are Kaken Pharmaceutical, Fibrocell Sciences, Inc., OraPharma, Inc., and DexcelPharma, among others, as per this study.
Transparency Market Research
90 State Street,
NY – 12207
USA – Canada Toll Free 866-552-3453